SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001908766-22-000002
Filing Date
2022-02-04
Accepted
2022-02-04 16:08:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g.txt SC 13G 6770
  Complete submission text file 0001908766-22-000002.txt   8393
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Subject) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-79890 | Film No.: 22593293
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2121 N. CALIFORNIA BLVD. SUITE 610 WALNUT CREEK CA 94596
Business Address
Ness Kevin Dean (Filed by) CIK: 0001908766 (see all company filings)

Type: SC 13G